2024/11/01 09:30:42 | |
---|---|
Price | |
114.60 EUR | |
Difference | 1.19% (1.35) |
ISIN | DK0060448595 |
Symbol | COLO B |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 23,714 EUR |
Benchmark | OMX COPENHAGEN 20 |
Bid (Bid size) | 115.75 EUR (180) |
Ask (Ask size) | 116.15 EUR (180) |
Open | 113.65 EUR |
High | 114.60 EUR |
Low | 113.65 EUR |
Close (prev. day) | 113.25 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2023/10/27 | Global Equity Ratings | ||
2023/10/27 | Aktienempfehlungen Global | ||
2023/09/29 | Global Equity Ratings | ||
2023/09/29 | Aktienempfehlungen Global | ||
2023/09/08 | Global Equity Ratings |
2024/11/01 09:30:42 | |
---|---|
Price | |
114.60 EUR | |
Difference | 1.19% (1.35) |
ISIN | DK0060448595 |
Symbol | COLO B |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 23,714 EUR |
Benchmark | OMX COPENHAGEN 20 |
Bid (Bid size) | 115.75 EUR (180) |
Ask (Ask size) | 116.15 EUR (180) |
Open | 113.65 EUR |
High | 114.60 EUR |
Low | 113.65 EUR |
Close (prev. day) | 113.25 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
6M | 1Y | 3Y | |
Perf (%) | +0.27% | +14.90% | -20.33% |
Perf (abs.) | +0.30 | +14.69 | -28.90 |
Beta | 0.12 | 0.27 | 0.55 |
Volatility | 22.10 | 26.83 | 28.13 |
Ø price 5 days | Ø volume 5 days (pcs.) | 117.40 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 117.61 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 118.07 EUR (2) |
Ø price 250 days | Ø volume 250 days (pcs.) | 114.55 EUR (2) |
YTD High | date | 130.60 EUR (2024/03/12) |
YTD Low | date | 101.65 EUR (2024/01/05) |
52 Weeks High | date | 130.60 EUR (2024/03/12) |
52 Weeks Low | date | 92.56 EUR (2023/11/10) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/11/01 | 09:04 | 114.90 EUR | 0.00 | 2 |
Vienna Stock Exchange | 2024/11/01 | 11:00 | 115.40 EUR | 0.00 | 2 |
Tradegate | 2024/11/01 | 10:23 | 115.30 EUR | 0.00 | 5 |
Stuttgart | 2024/11/01 | 08:04 | 113.90 EUR | 0.00 | 1 |
SIX Swiss Exchange | 2020/04/09 | 17:36 | 111.00 CHF | 0.00 | 1 |
Nasdaq Copenhagen | 2024/11/01 | 12:06 | 864.60 DKK | 16.53 | 604 |
Munich | 2024/11/01 | 08:04 | 114.95 EUR | 0.00 | 1 |
London Stock Exchange European Trade Reporting | 2024/11/01 | 09:00 | 855.30 DKK | 0.00 | 1 |
Hanover | 2024/11/01 | 08:01 | 113.75 EUR | 0.00 | 1 |
Frankfurt | 2024/11/01 | 08:04 | 113.95 EUR | 0.00 | 1 |
FINRA other OTC Issues | 2024/10/29 | 18:19 | 126.1701 USD | 0.47 | 4 |
Duesseldorf | 2024/11/01 | 09:30 | 114.60 EUR | 0.00 | 2 |
Berlin | 2024/11/01 | 11:44 | 115.60 EUR | 0.00 | 6 |
COLOPLAST A/S |
- - |
Holtedam 1-3 - 3050 Humlebaek |
Telefon: +45-49-11-11-11 |
Fax: + |
E-mail: - |
Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Voice and Respiratory Care segment refers to the sale of laryngectomy and tracheostomy products. The Interventional Urology segment includes the sale of urological products, including disposable products. The Advanced Wound Dressings segment focuses on the sale of wound and skin care products. The Biologics segment represents a new segment covering the sale of tissue-based products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark. |
Kristian Villumsen | Chairman of Managing Board |
Allan Rasmussen | Member of Executive Committee |
Anders Lonning-Skovgaard | Member of Executive Committee |
Dorthe Ronnau | Member of Executive Committee |
Nicolai Buhl Andersen | Member of Executive Committee |
Paul Marcun | Member of Executive Committee |
Lars Søren Rasmussen | Chairman of Supervisory Board |
Annette Brüls | Member of Supervisory Board |
Carsten Hellmann | Member of Supervisory Board |
Jette Nygaard-Andersen | Member of Supervisory Board |
Marianne Wiinholt | Member of Supervisory Board |
Niels Peter Louis-Hansen | Member of Supervisory Board |
Nikolaj Kyhe Gundersen | Member of Supervisory Board |
Roland Vendelbo Pedersen | Member of Supervisory Board |
Thomas Barfod | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.